Form 4: Nutex Health Executive Elisa Luqman Reports Stock Transactions

Chief Legal Officer Elisa Luqman reports acquisition and disposal of Nutex Health stock and restricted stock units.

Summary

• Elisa Luqman, Chief Legal Officer of Nutex Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2025, Luqman acquired 1,250 shares of common stock upon conversion of restricted stock units (RSUs).
• On April 4, 2025, 266 shares were disposed of to cover tax withholding obligations at a price of $72.0972 per share.
• Luqman directly owns 1,060 shares and indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 1,070 shares.
• Luqman also holds 5,000 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of compliance for corporate insiders and provide transparency into their trading activities. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
• The transactions reported are typical for executives receiving stock-based compensation and managing their tax obligations.
• Similar filings can be observed across various companies like UnitedHealth Group (UNH) or Johnson & Johnson (JNJ) when their executives exercise stock options or sell shares.

Stakeholder Impact

• Shareholders gain insight into the trading activities of a key executive.
• The transactions may have a minor impact on the stock's trading volume.

Key Dates

Keywords

Form 4, Beneficial Ownership, Nutex Health, Stock Transactions, Restricted Stock Units, Elisa Luqman, NUTX